Pannexin 1 (Panx1) forms plasma membrane ion channels that release important intercellular signalling molecules, specifically ATP and UTP, under pathological and physiological conditions; the channels also support uptake of various fluorescent dyes that have traditionally been used to mark apoptotic cells (e.g., YO-PRO-1, TO-PRO-3). In this PPG application, novel mouse models are employed to ascertain contributions of Panx1- mediated ATP/UTP release, (and other metabolite release, when needed) to various aspects of cardiometabolic diseases, and to understand corresponding mechanisms of Panx1 channel activation. Cell Physiology Core centralizes the functional analysis of Pannexin channels by absorbing, optimizing and standardizing the key assays of universal significance to all four projects. These include: (1) Analysis of Panx1 channel function in primary cells by electrophysiology and dye uptake assays and; (2) Electrophysiological characterization of novel small molecule modulators of Pannexin channels. Similarly, the core also takes the initiative in the development of innovative tools and methods that can provide a clear technical edge to the entire research program. This includes generation of novel Panx1 variants and gene-edited mouse lines, generated by CRISPR/Cas9 technology. In executing these centralized goals, often of salience to the entire research program, the core recognizes the paramount importance of data quality and reproducibility. For the vertical and horizontal integration proposed in this PPG, this core sits at the interface between cellular and systems levels of analysis of Panx1 function.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL120840-07
Application #
9894838
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Program Officer
OH, Youngsuk
Project Start
Project End
Budget Start
2020-06-01
Budget End
2021-05-31
Support Year
7
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Virginia
Department
Type
DUNS #
065391526
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Serbulea, Vlad; Upchurch, Clint M; Schappe, Michael S et al. (2018) Macrophage phenotype and bioenergetics are controlled by oxidized phospholipids identified in lean and obese adipose tissue. Proc Natl Acad Sci U S A 115:E6254-E6263
Adamson, Samantha E; Montgomery, Garren; Seaman, Scott A et al. (2018) Myeloid P2Y2 receptor promotes acute inflammation but is dispensable for chronic high-fat diet-induced metabolic dysfunction. Purinergic Signal 14:19-26
Kerur, Nagaraj; Fukuda, Shinichi; Banerjee, Daipayan et al. (2018) cGAS drives noncanonical-inflammasome activation in age-related macular degeneration. Nat Med 24:50-61
Morioka, Sho; Perry, Justin S A; Raymond, Michael H et al. (2018) Efferocytosis induces a novel SLC program to promote glucose uptake and lactate release. Nature 563:714-718
Brown, Isola A M; Diederich, Lukas; Good, Miranda E et al. (2018) Vascular Smooth Muscle Remodeling in Conductive and Resistance Arteries in Hypertension. Arterioscler Thromb Vasc Biol 38:1969-1985
Penberthy, Kristen K; Lysiak, Jeffrey J; Ravichandran, Kodi S (2018) Rethinking Phagocytes: Clues from the Retina and Testes. Trends Cell Biol 28:317-327
Chiu, Yu-Hsin; Schappe, Michael S; Desai, Bimal N et al. (2018) Revisiting multimodal activation and channel properties of Pannexin 1. J Gen Physiol 150:19-39
DeLalio, Leon J; Keller, Alexander S; Chen, Jiwang et al. (2018) Interaction Between Pannexin 1 and Caveolin-1 in Smooth Muscle Can Regulate Blood Pressure. Arterioscler Thromb Vasc Biol 38:2065-2078
Nyberg, Michael; Piil, Peter; Kiehn, Oliver T et al. (2018) Probenecid Inhibits ?-Adrenergic Receptor-Mediated Vasoconstriction in the Human Leg Vasculature. Hypertension 71:151-159
Serbulea, Vlad; Upchurch, Clint M; Ahern, Katelyn W et al. (2018) Macrophages sensing oxidized DAMPs reprogram their metabolism to support redox homeostasis and inflammation through a TLR2-Syk-ceramide dependent mechanism. Mol Metab 7:23-34

Showing the most recent 10 out of 38 publications